Nick Haft
Board Observer

    Nick is a Board Observer. He is a Co-Founder and Managing Director of OMX Ventures. Prior to OMX, Nick was the sole managing partner at Arcos Ventures, where he deployed over $80M of capital into 20+ bio-related companies. Nick also co-founded Delix Therapeutics, a startup focused on developing breakthrough therapies for psychiatric and neurological disorders. Nick graduated with a Bachelor of Science in Economics, Wharton School, University of Pennsylvania.

    Join Replay

    Help us to author the future of genomic medicine